Virtus ETF Advisers’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,688
| Closed | -$67.9K | – | 502 |
|
|
2024
Q4 | $67.9K | Buy |
2,688
+159
| +6% | +$4.32K | 0.03% | 397 |
|
|
2024
Q3 | $86K | Buy |
2,529
+44
| +2% | +$1.68K | 0.04% | 400 |
|
|
2024
Q2 | $92K | Buy |
2,485
+86
| +4% | +$3.25K | 0.05% | 351 |
|
|
2024
Q1 | $101K | Sell |
2,399
-162
| -6% | -$6.65K | 0.05% | 362 |
|
|
2023
Q4 | $102K | Sell |
2,561
-70
| -3% | -$2.06K | 0.06% | 350 |
|
|
2023
Q3 | $72.4K | Sell |
2,631
-261
| -9% | -$8.18K | 0.04% | 377 |
|
|
2023
Q2 | $98.1K | Buy |
2,892
+379
| +15% | +$12.8K | 0.06% | 394 |
|
|
2023
Q1 | $90.4K | Sell |
2,513
-967
| -28% | -$41.7K | 0.05% | 362 |
|
|
2022
Q4 | $155K | Sell |
3,480
-1,367
| -28% | -$48.8K | 0.08% | 336 |
|
|
2022
Q3 | $136K | Buy |
4,847
+31
| +0.6% | +$950 | 0.05% | 367 |
|
|
2022
Q2 | $130K | Buy |
4,816
+685
| +17% | +$19.9K | 0.05% | 351 |
|
|
2022
Q1 | $141K | Sell |
4,131
-251
| -6% | -$8.02K | 0.06% | 234 |
|
|
2021
Q4 | $169K | Sell |
4,382
-3,483
| -44% | -$152K | 0.06% | 290 |
|
|
2021
Q3 | $425K | Sell |
7,865
-435
| -5% | -$20.4K | 0.19% | 164 |
|
|
2021
Q2 | $278K | Sell |
8,300
-8,164
| -50% | -$224K | 0.11% | 204 |
|
|
2021
Q1 | $339K | Buy |
16,464
+290
| +2% | +$6.66K | 0.14% | 214 |
|
|
2020
Q4 | $283K | Buy |
+16,174
| New | +$291K | 0.12% | 241 |
|
|
2018
Q2 | – | Sell |
-17,095
| Closed | -$597K | – | 264 |
|
|
2018
Q1 | $597K | Buy |
17,095
+9,164
| +116% | +$355K | 0.52% | 106 |
|
|
2017
Q4 | $338K | Sell |
7,931
-1,387
| -15% | -$59.4K | 0.42% | 104 |
|
|
2017
Q3 | $400K | Buy |
9,318
+852
| +10% | +$31.9K | 0.05% | 111 |
|
|
2017
Q2 | $314K | Buy |
8,466
+3,450
| +69% | +$153K | 0.05% | 114 |
|
|
2017
Q1 | $272K | Buy |
5,016
+481
| +11% | +$25K | 0.05% | 149 |
|
|
2016
Q4 | $241K | Buy |
4,535
+566
| +14% | +$32.2K | 0.07% | 153 |
|
|
2016
Q3 | $241K | Hold |
3,969
| – | – | 0.12% | 127 |
|
|
2016
Q2 | $261K | Buy |
3,969
+2,819
| +245% | +$179K | 0.19% | 81 |
|
|
2016
Q1 | $65K | Buy |
+1,150
| New | +$129K | 0.09% | 149 |
|
Other funds holding CLDX
KCM
EAM
CC
BG
